You must be logged in to post a review.
The Device Trial
The Device Trial, by Tom Breen, takes readers into a world of sketchy businessmen and lawyers, teetering on the line between right and wrong from beginning to end. Lawyer Brian Bradford has just won a billion dollar lawsuit against medical company, ZeiiMed headed, at the time, by John Edison. However, his victory in the courtroom came at a high personal cost, and revenge now drives him to make Edison pay personally. A fight in Central Park one night lands both in the hospital with serious injuries. As both men heal and go about their lives, with a deep disdain for one another that could come to a head at any moment, Bradford comes across another possible lawsuit against MendMed, a company owned by ZeiiMed. This involves a device for those needing hip replacements and its possible defects. Bradford and his associate, Mary, take on the case. Justice is wanted by all, both in and out of the courtroom. Who will win and who will survive is the biggest question of all.
The Device Trial is a thrilling suspense novel from beginning to end. Well written and engaging, the storyline is fast-paced and will keep the reader’s attention from the first page to the last. The characters are well developed and add to the novel as a whole. Breen does a great job taking the topic of medical devices and their purposes, as well as medical terminology, and makes them easy to read without taking away from the story’s overall plot and pace. Breen also does a fantastic job of taking readers into the courtroom setting and doing the same. I am giving this novel a solid 5-star rating. Anyone who is a fan of thrillers, suspense and medical and/or legal novels should definitely read The Device Trial.
Author | Tom Breen |
---|---|
Star Count | /5 |
Format | Hard |
Page Count | 314 pages |
Publisher | Pegasus Books |
Publish Date | 2016-07-01 |
ISBN | 9781941859476 |
Bookshop.org | Buy this Book |
Issue | October 2016 |
Category | Mystery, Crime, Thriller |
Share |
Reviews
There are no reviews yet.